Secura Bio

While many lymphomas are relatively common, certain subtypes of lymphomas are quite rare cancers. As a team working diligently to give patients with rare t-cell lymphoma subtypes new treatment options and more hope for the future, we value opportunities to spread disease awareness.

Tomorrow, on Rare Disease Day, we are reminded of all the many individuals globally waiting for new or alternative therapeutic approaches to address their unmet needs as they navigate serious and rare conditions.

Dr. Christiane Langer, Senior Vice President, Head of Clinical & Medical Affairs at Secura Bio, offers her perspective on Rare Disease Day and specifically the diagnostic journey with rare blood cancers.

To learn about Rare Disease Day, please visit: https://www.rarediseaseday.org/